Issue 30, 2014

Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

Abstract

This communication demonstrates the possibility to nucleate and grow different crystalline polymorphic forms of gabapentin (GBP) using, as nucleation templates, Langmuir monolayers of an amphiphilic calixarene at different packing densities.

Graphical abstract: Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

Supplementary files

Article information

Article type
Communication
Submitted
04 Feb 2014
Accepted
20 Feb 2014
First published
05 Mar 2014

Chem. Commun., 2014,50, 3938-3940

Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

L. G. Tulli, N. Moridi, W. Wang, K. Helttunen, M. Neuburger, D. Vaknin, W. Meier and P. Shahgaldian, Chem. Commun., 2014, 50, 3938 DOI: 10.1039/C4CC00928B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements